ArticleCureus2023
Assessment of Understandability and Actionability of YouTube Videos on Hemolytic Disease of the Newborn.
Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Patient experience and burden of haemolytic disease of the foetus and newborn: a systematic review.BMC pregnancy and childbirth · 2025Pooled it
- Decoding YouTube: An In-depth Analysis of Living Donor Kidney Transplantation Videos and Their Implications for Patient Education.European urology open science · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction With revolutions in Information Technology, information and misinformation are easier to be found online. YouTube is the largest and most commonly searched video content website in the world. It is assumed that, due to the coronavirus pandemic, most patients try to know about diseases through the internet and reduce the number of hospital exposures unless otherwise. In order to assess the understandability and actionability of such YouTube videos available freely online about the disease, Hemolytic disease of the newborn (HDN), this study was planned. Methods This is a cross-sectional study conducted with the first 160 videos available on May 14, 2021, with the search keyword "HDN" with a relevance filter and a duration of 4 to 20 minutes. The videos were further screened regarding the information content and language. These videos were assessed by three independent assessors using the patient educational materials assessment tool for audio-visual content. Results Out of the first 160 videos selected for screening, 58 videos were excluded due to a lack of content about the searched disease "HDN". Another 63 videos were excluded due to the language of instruction not being in English. Finally, 39 videos were assessed by three assessors. The understandability and actionability responses were checked for reliability and a Cronbach's alpha of 93.6% was found, indicating good data reliability. To reduce subjectivity, average scores of understandability and actionability were taken based on the scores of these three assessors. There were eight and 34 videos with average understandability and actionability scores of <70% respectively. The median average understandability and actionability scores were 84.4% and 50% respectively. There was a statistically significant difference between understandability and actionability scores with considerably lower actionability scores of YouTube videos on the disease, HDN (p<0.001). Conclusion There is a great need to include actionable information by content developers in videos. Most information available has adequate understandable content making it easier for the general public to know about the diseases. YouTube and similar social sites thus possibly are helping in the dissemination of information promoting awareness among the public in general and patients in particular.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.